Evidence map›Paper›PMID 27548144›Full record

ArticleInternational journal of molecular sciences2016

MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.

Tomomi Fujii, Keiji Shimada, Aya Asano, Yoshihiro Tatsumi, Naoko Yamaguchi, Masaharu Yamazaki, Noboru Konishi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Neuropilin (NRPs) Related Pathological Conditions and Their Modulators.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tomomi FujiiDepartment of Pathology, Nara Medical University School of Medicine, Nara 634-8521, Japan. fujiit@naramed-u.ac.jp.
Keiji ShimadaDepartment of Diagnostic Pathology, Nara City Hospital, Nara 630-8305, Japan. k-shimada@nara-jadecom.jp.
Aya AsanoDepartment of Pathology, Nara Medical University School of Medicine, Nara 634-8521, Japan. ayaasano1018@yahoo.co.jp.
Yoshihiro TatsumiDepartment of Pathology, Nara Medical University School of Medicine, Nara 634-8521, Japan. tatsumi3@naramed-u.ac.jp.
Naoko YamaguchiDepartment of Central Clinical Laboratory, Nara Medical University Hospital, Nara 634-8521, Japan. nyama@naramed-u.ac.jp.
Masaharu YamazakiDepartment of Central Clinical Laboratory, Nara Medical University Hospital, Nara 634-8521, Japan. masayama@naramed-u.ac.jp.
Noboru KonishiDepartment of Pathology, Nara Medical University School of Medicine, Nara 634-8521, Japan. nkonishi@naramed-u.ac.jp.
Nara Medical University · JPNara Medical University Hospital · JPNara City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant expression of microRNAs (miRNAs) is involved in the development and progression of various types of cancers. In this study, we investigated the role of miR-331-3p in cell proliferation and the expression of keratinocyte differentiation markers of uterine cervical cancer cells. Moreover, we evaluated whether neuropilin 2 (NRP2) are putative target molecules that regulate the human papillomavirus (HPV) related oncoproteins E6 and E7. Cell proliferation in the human cervical cancer cell lines SKG-II, HCS-2, and HeLa was assessed using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. Cellular apoptosis was measured using the TdT-mediated dUTP nick end labeling (TUNEL) and Annexin V assays. Quantitative RT-PCR was used to measure the messenger RNA (mRNA) expression of the NRP2, E6, E7, p63, and involucrin (IVL) genes. A functional assay for cell growth was performed using cell cycle analyses. Overexpression of miR-331-3p inhibited cell proliferation, and induced G2/M phase arrest and apoptosis in SKG-II, HCS-2 and HeLa cells. The luciferase reporter assay of the NRP2 3'-untranslated region revealed the direct regulation of NRP2 by miR-331-3p. Gene expression analyses using quantitative RT-PCR in SKG-II, HCS-2, and HeLa cells overexpressing miR-331-3p or suppressing NRP2 revealed down-regulation of E6, E7, and p63 mRNA and up-regulation of IVL mRNA. Moreover, miR-331-3p overexpression was suppressed NRP2 expression in protein level. We showed that miR-331-3p and NRP2 were key effectors of cell proliferation by regulating the cell cycle, apoptosis. NRP-2 also regulates the expression of E6/E7 and keratinocyte differentiation markers. Our findings suggest that miR-331-3p has an important role in regulating cervical cancer cell proliferation, and that miR-331-3p may contribute to keratinocyte differentiation through NRP2 suppression. miR-331-3p and NRP2 may contribute to anti-cancer effects.

Indexed as

Cell CycleCell Line, TumorCell ProliferationCell SurvivalFemaleHeLa CellsHumansIn Situ Nick-End LabelingKeratinocytesMicroRNAsNeuropilin-2Oncogene Proteins, ViralUterine Cervical NeoplasmsMicroRNAsMIRN331 microRNA, humanNeuropilin-2Oncogene Proteins, Viralcervical cancerE6/E7 mRNAhuman papillomaviruskeratinocyte differentiationmiR-331-3pneuropilin 2

Identifiers

PMID27548144
PMCPMC5000747
OpenAlexW2509821720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.